In-Person Registration for Industry Professionals | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Use of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of lymphoma.